Clinical Trials at Hopital Purpan
During the past decade, Hopital Purpan conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 9 clinical trials were completed, i.e. on
average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 3 clinical trials were completed. i.e. 33.3%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Hopital Purpan" #1 sponsor was "Pfizer" with 6 trials, followed by "Centre Hospitalier Universitaire de Nīmes" with 4 trials
sponsored, "Biogen" with 3 trials sponsored, "Hoffmann-La Roche" with 3 trials sponsored and "Advicenne Pharma"
with 3 trials sponsored. Other sponsors include 13 different institutions and
companies that sponsored additional 19 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Hopital Purpan"
#1 collaborator was "Intergroupe Francophone du Myelome" with 2 trials as a collaborator, "Baxalta Innovations GmbH, now part of Shire" with 1 trials as a collaborator, "Celgene" with 1 trials as a collaborator and "Institut National de la Santé Et de la Recherche Médicale, France" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Hopital Purpan
According to Clinical.Site data, the most researched conditions in "Hopital Purpan" are
"Alzheimer Disease" (3 trials), "Cystinuria" (2 trials), "Glioblastoma" (2 trials), "Hemophilia A" (2 trials) and "Psoriatic Arthritis" (2 trials). Many other conditions were trialed in "Hopital Purpan" in a lesser frequency.
Clinical Trials Intervention Types at Hopital Purpan
Most popular intervention types in "Hopital Purpan" are "Drug" (23 trials), "Biological" (6 trials), "Other" (6 trials), "Device" (2 trials) and "Genetic" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (8 trials), "placebo" (3 trials), "ADV7103" (2 trials), "Bevacizumab" (2 trials) and "etanercept" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Hopital Purpan
The vast majority of trials in "Hopital Purpan" are
36 trials for "All" genders.
Clinical Trials Status at Hopital Purpan
Currently, there are NaN active trials in "Hopital Purpan".
1 are not yet recruiting,
3 are recruiting,
5 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 18 completed trials in Hopital Purpan,
undefined suspended trials,
and 7 terminated clinical trials to date.
Out of the total trials that were conducted in Hopital Purpan, 0 "Phase 1"
clinical trials were conducted, 6 "Phase 2" clinical
trials and 17 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 4 trials, and there were
also 3 trials that are defined as “Not Applicable".